Clinical trial
Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone
NCT00161421 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00161421 |
|---|---|
| Title | Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone |
| Official title | Oral Androgens in Man-3: Pharmacokinetics of Oral Testosterone With Concomitant Inhibition of 5α-Reductase by Dutasteride Short Title: ORAL T-3 |
| Lead sponsor | University of Washington, Other |
| Collaborators | GlaxoSmithKline Industry National Institutes of Health (NIH) NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Contraception, Hypogonadism |
| Intervention type | Drug |
| Interventions | Oral Testosterone, Leuprolide (Lupron), Dutasteride |
| Enrollment | 18 |
| Start date | Mar 1, 2005 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 19, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: